Konica’s bio-injectable products include preparation devices for platelet-rich plasma and other blood cell therapies, administered using ultrasound guidance.
The single use kits prepare PRP and other cell-based therapies so clinicians can deliver efficiently in their practice.
The regenerative medicine market for sports medicine, orthopedics and pain management is projected to surpass $300 million in North America by 2025, according to a recent report by Grand View Research.
More articles on biologics:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
